205754-33-2 (8-羟基依法韦伦,8-Hydroxy Efavirenz (~90%))

8 - 羟基依法韦仑标准品;8-羟基依法韦仑;8-羟基依法韦伦;

2H-3,1-Benzoxazin-2-one,6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-,(4S)-;8-Hydroxy Efavirenz;2H-3,1-Benzoxazin-2-one,6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluorome...;RAC 8-HYDROXY EFAVIRENZ;(S)-6-chloro-4-(cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one;6-Chloro-4-(cyclopropyl-d4-ethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;205754-33-2;OOVOMPCQLMFEDT-ZDUSSCGKSA-N;NS00116200;CHEMBL1309;CS-0138367;8-hydroxy EFV;BDBM50097571;8-Hydroxy Efavirenz (~90%);(4S)-6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one;8-OH efavirenz;(4S)-6-chloro-4-(2-cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one;2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-, (4S)-;8-OH EFV;8-hydroxy-efavirenz-glucuronide;2H-3,1-Benzoxazin-2-one,6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-8-hydroxy-4-(trifluoromethyl)-, (4S)-;P8S49CKH6L;8-Hydroxy-efavirenz;A935414;6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-4H-3,1-benzoxazine-2,8-diol;HY-137397;UNII-P8S49CKH6L;AKOS030255837;DTXSID50942769;Q27286382;8-Hydroxyefavirenz;6-chloro-4-(cyclopropylethynyl)-8-hydroxy-4-(trifluoromethyl)-1,4-dihydro-2h-3,1-benzoxazin-2-one;PD117321;(S)-6-Chloro-4-cyclopropylethynyl-8-hydroxy-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one;G90704;DA-50018;

OOVOMPCQLMFEDT-ZDUSSCGKSA-N

1S/C14H9ClF3NO3/c15-8-5-9-11(10(20)6-8)19-12(21)22-13(9,14(16,17)18)4-3-7-1-2-7/h5-7,20H,1-2H2,(H,19,21)/t13-/m0/s1

ClC1C=C(C2=C(C=1)[C@](C(F)(F)F)(C#CC1CC1)OC(N2)=O)O